AstraZeneca makes surprise U-turn with £300m pharma investment

Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year. The drugmaker had pulled back projects in Britain after becoming disillusioned with the business environment, including the availability of new medicines on the NHS and drug pricing. On Wednesday, it said it would invest in two existing sites at Cambridge and Macclesfield. …